Anaphylactic Reactions Caused by Nafamostat Mesylate during Hemodialysis before Surgery for Carpal Tunnel Syndrome
Nafamostat mesylate (NM) has been used to treat pancreatitis and disseminated intravascular coagulation during hemodialysis (HD). However, there have been some reports of adverse effects related to anaphylactic reactions. We present a case in which anaphylactic reactions caused by NM during preopera...
Saved in:
| Main Authors: | Yuta Nakamura, Kaoru Tada, Masashi Matsuta, Atsuro Murai, Hiroyuki Tsuchiya |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Case Reports in Nephrology |
| Online Access: | http://dx.doi.org/10.1155/2021/1148156 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nafamostat mesylate augments survival in rats afflicted by exertional heat stroke
by: Qingwei Lin, et al.
Published: (2025-05-01) -
Nafamostat Mesylate Regulates Glycosylation to Alleviate Aristolochic Acid Induced Kidney Injury
by: Pei Xie, et al.
Published: (2025-03-01) -
Nafamostat mesylate versus regional citrate anticoagulation for chronic hemodialysis in patients at high risk of bleeding: a single-center, retrospective study
by: Jiangtao Li, et al.
Published: (2025-12-01) -
Comparison of regional citrate anticoagulation and nafamostat mesylate anticoagulation during plasma exchange for children at high bleeding risk: a retrospective study
by: Dan Peng, et al.
Published: (2025-04-01) -
Integrative anticoagulation of nafamostat mesylate in double plasma molecular adsorption system plus sequential half-dose plasmapheresis for patients with liver failure: a randomised controlled trial protocol
by: Lang Bai, et al.
Published: (2025-02-01)